Encellin
Pre-clinicalEncellin is focused on advancing next generation therapies, starting with endocrine disorders.
Founded
2015
Focus
Drug Delivery
About
Encellin is focused on advancing next generation therapies, starting with endocrine disorders.
Funding History
2Total raised: $17M
Series A$12MUndisclosedJun 15, 2021
Seed$5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile